Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20230826010
TCTR20230826010
Recruiting
Not Applicable

Glycemic profiles assessment by continuous glucose monitoring in automated peritoneal dialysis patients.

Routine to Research, Faculty of medicine, Siriraj hospital0 sites30 target enrollmentAugust 26, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGlycemic control in end stage kidney disease patients who on automated peritoneal dialysisend stage kidney disease, automated peritoneal dialysis, peritoneal dialysis, continuous glucose monitoring, glycemic profile, time in range, diabetes mellitus

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glycemic control in end stage kidney disease patients who on automated peritoneal dialysis
Sponsor
Routine to Research, Faculty of medicine, Siriraj hospital
Enrollment
30
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 26, 2023
End Date
April 30, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Routine to Research, Faculty of medicine, Siriraj hospital

Eligibility Criteria

Inclusion Criteria

  • •1\.End stage renal disease on automated peritoneal dialysis patients, which initiated more than 1 month and performed peritoneal equilibration test within 6 months
  • •2\.Age \>/\= 18 year
  • •3\.Accepted in CGM and can perform self\-monitoring blood glucose

Exclusion Criteria

  • •1\. Need to change regimen in automated peritoneal dialysis within 7 days
  • •2\. Hospitalized or diagnosed peritonitis within 4 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Glucose tolerance evaluation by continuous glucose monitoring (CGM) after gestational diabetes
JPRN-UMIN000034547Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan20
Not yet recruiting
Phase 4
Role of continuous glucose monitoring device on diabetes patientHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2024/02/062647Dr.Priyamadhabha Behera
Recruiting
Not Applicable
The assessment of glycemic excrusion using continuous glucose monitoring in postoperative gastric cancer patients.gastric cancer
JPRN-UMIN000041219Tokyo Metropolitan Tama Medical Center Department of Surgery8
Completed
Not Applicable
Continuous glucose monitoring (CGM) in advanced neurodegenerative diseasesneurodegenerative diseases0
JPRN-jRCT1090220372ational Health Organization Hyogo-Chuo National Hospital10
Completed
Not Applicable
Monitoring of plasma glucose using continuous glucose measurement system (CGMs) in patients with peritoneal dialysisperitoneal dialysis patients
JPRN-UMIN000014916Department of Nephrology, Fujita Health University School of Medicine50